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Abstract
Background: Despite the high prevalence and impact of episodic breathlessness, information about characteristics and patterns is 
scarce.
Aim: To explore the experience of patients with advanced disease suffering from episodic breathlessness, in order to describe types 
and patterns.
Design and participants: Qualitative design using in-depth interviews with patients suffering from advanced stages of chronic heart 
failure, chronic obstructive pulmonary disease, lung cancer or motor neurone disease. As part of the interviews, patients were asked 
to draw a graph to illustrate typical patterns of breathlessness episodes. Interviews were tape-recorded, transcribed verbatim and 
analysed using Framework Analysis. The graphs were grouped according to their patterns.
Results: Fifty-one participants (15 chronic heart failure, 14 chronic obstructive pulmonary disease, 13 lung cancer and 9 motor 
neurone disease) were included (mean age 68.2 years, 30 of 51 men, mean Karnofsky 63.1, mean breathlessness intensity 3.2 of 
10). Five different types of episodic breathlessness were described: triggered with normal level of breathlessness, triggered with 
predictable response (always related to trigger level, e.g. slight exertion causes severe breathlessness), triggered with unpredictable 
response (not related to trigger level), non-triggered attack-like (quick onset, often severe) and wave-like (triggered or non-triggered, 
gradual onset). Four patterns of episodic breathlessness could be identified based on the graphs with differences regarding onset and 
recovery of episodes. These did not correspond with the types of breathlessness described before.
Conclusion: Patients with advanced disease experience clearly distinguishable types and patterns of episodic breathlessness. 
The understanding of these will help clinicians to tailor specific management strategies for patients who suffer from episodes of 
breathlessness.
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Introduction
About half of the patients with advanced and life-limiting 
diseases experience breathlessness despite optimal treat-
ment of the underlying condition.1 Some patients suffer 
from continuous breathlessness (breathlessness all the 
time), but the majority describe episodes of breathlessness 
(intermittent breathlessness) or a combination of both.2,3 
Patients with chronic obstructive pulmonary disease 
(COPD) or cancer describe that episodic breathlessness 
triggers anxiety, panic and even the fear to die.4 The emo-
tional response to episodic breathlessness (mainly panic) 
leads to a vicious circle triggering breathlessness itself.5 
Despite the high prevalence, more detailed information 
about episodic breathlessness is scarce.6 In 70 cancer 
patients, breathlessness episodes occurred frequently 
(81%), most often 1–5 times/day and lasted less than 10 
min (88%).2 Booth et al.7 indicated differences between 
patients with cancer and COPD regarding the patterns and 
course of episodic breathlessness, for example, the quick 
onset of an episode without a warning signal was reported 
only by patients with cancer. Four randomized controlled 
trials (RCTs) evaluated pharmacological interventions for 
episodic breathlessness, but only one study provided rather 
limited information about the frequency (1–2 episodes/
day).8–11
Better understanding of patients’ experience of episodic 
breathlessness and its patterns is needed to improve treat-
ment options. Therefore, we aimed to explore the experi-
ence of patients with advanced and life-limiting diseases 
suffering from episodic breathlessness, and describe types 
and patterns of episodes of breathlessness.
Methods
Design
We used a qualitative study design with in-depth face-to-
face interviews. This study followed the consolidated crite-
ria for reporting qualitative research (COREQ) guideline 
for reporting qualitative research.12
Participants and recruitment
A purposive sample of patients aged >18 years, suffering 
from breathlessness due to COPD (stage III/IV of the 
Global Initiative for Obstructive Lung Disease (GOLD) 
classification), chronic heart failure (CHF), stage II-IV of 
the New York Heart Association (NYHA) classification, 
lung cancer (LC; primary and secondary LC, all stages), 
and motor neurone disease (MND; all stages).13,14 Patients 
could be on any treatment with regard to the underlying 
disease or breathlessness. Lack of capacity to give 
informed consent and cognitive impairment, as judged 
by the principal investigator, were exclusion criteria. 
Interviews were conducted until no new information was 
gained, and saturation was achieved. Participants were 
recruited at five out-patient clinics of two university hospi-
tals in South London over a 6-month period in 2010. 
Informed consent was obtained from the patients at least 
24 h before the interview.
Interview procedure
The in-depth face-to-face interviews were conducted by 
two trained interviewers (S.T.S. (male, physician), H.B. 
(male, sociologist)), usually in the participant’s home. 
Demographic and clinical data were obtained before the 
interview started. We chose a semi-structured approach to 
explore patients’ experiences using a topic guide, including 
general experience with breathlessness; experiences, char-
acteristics and triggers of episodic breathlessness and its 
patterns; and impact on daily living, management strategies 
and health-care use. We defined episodic breathlessness 
following Reddy’s suggestions as ‘breathlessness occurring 
intermittently with and without underlying continuous 
breathlessness’.2
At the end of the interview, we asked the participant to 
draw at least one graph to illustrate the pattern of a typical 
episode of breathlessness. We used a coordinate system 
with two axes (x = time line, participant defined whether 
unit was minutes, hours or days; y = severity of breathless-
ness; see Figure 2).
All interviews were tape-recorded and transcribed ver-
batim. The interviewers kept field notes of each interview 
in participant-related memos.
Data analysis
The interviews were analysed using Framework Analysis. 
This is a matrix-based method using a thematic framework 
to classify and organize data by key themes, concepts and 
categories.15 First, all interviews and memos were read 
twice by the principal investigator (S.T.S.) to familiarize 
with the content. The following analytic hierarchy guided 
the analysis: data management (identifying initial themes, 
coding), descriptive accounts (sorting, summarizing, 
identifying dimensions and categories) and explanatory 
accounts (detecting patterns, identifying clusters, develop-
ing explanations and a theory). The stages of descriptive 
and explanatory accounts were facilitated by creating the-
matic charts in particular for thematic-related (inter-partic-
ipant) and participant-related (inter-thematic) analysis. The 
analysis was conducted by S.T.S. At the beginning, five 
interviews were coded by two additional researchers (C.B., 
F.M.) in order to address rigour and trustworthiness. At 
every analysis stage, findings were discussed and results 
of these discussions were incorporated. Special attention 
was paid to deviant cases (‘negative cases’, which contra-
dicted the emerging explanation) to describe the range of 
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Table 1. Demographic and clinical characteristics of participants.
Characteristics n = 51
Age, in years, mean (SD; range) 68.2 (11.6; 39–92)
Gender, n (%): male 30 (59)
Disease group (stage)  
 COPD 14 (7 GOLD III, 7 GOLD IV)
 LC (entity) 13 (7 primary LC, 4 mesothelioma, 2 secondary LC (breast))
 CHF 15 (2 NYHA II, 10 NYHA III, 3 NYHA IV)
 MND 9
Ethnicity, n (%)  
 White British 32 (63)
 White Others  7 (14)
 Black African  3 (6)
 Black Caribbean  5 (10)
 Indian  4 (8)
Living situation, n (%): alone 19 (37)
Karnofsky Index, mean (SD) 63.1 (14.1)
CCI, n (%): missing  4 (8)
 No risk  7 (14)
 Mild risk 18 (35)
 Moderate risk 11 (22)
 Severe risk 11 (22)
Smoking, n (%)  
 Still smoking  3 (6)
 Smoked but stopped 31 (61)
 Never smoked 17 (33)
Oxygen supply, n (%) 14 (28)
Severity of breathlessness in general, mod. Borg, mean (SD)  
 Average 24 h 3.2 (1.7)
 Worst 5.4 (2.4)
 Now 1.7 (1.6)
 Rest 1.2 (1.2)
 On exertion 5.4 (2.1)
SD: standard deviation; CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; GOLD: global initiative for chronic obstructive lung 
disease; LC: lung cancer; NYHA: New York Heart Association; CCI: Charlson Comorbidity Index.
experiences and meanings.16 The computer program NVivo 
8 (devised by QSR international in 2008) was used for data 
management.
The graphs illustrating the pattern of episodes of breath-
lessness were analysed with a descriptive approach using 
the following criteria: onset (quick or slow/gradual), recov-
ery (quick or slow/gradual) and presence of a plateau. 
Similar graphs were grouped in categories.
Ethics approval
The Joint University College London (UCL)/University 
College London Hospitals (UCLH) Committees on the 
Ethics of Human Research Alpha (09/H0715/81) provided 
ethical approval, and the study was registered on 
ClinicalTrials.gov (NCT01138358) and the National 
Institute for Health Research Clinical Research Network 
Portfolio (NIHR CRN Study ID 7859).
Results
Patients’ characteristics
Fifty-one participants were interviewed. Demographic and 
clinical details are shown in Table 1. The majority of inter-
views (45 of 51) were conducted in participants’ homes, two at 
the recruiting hospital and four at the investigators’ institute. 
Median length of interviews was 55 min (range 17–89 min).
Types of episodic breathlessness
Patients’ experiences and descriptions of episodes of 
breathlessness could be grouped into five main types: Type 
1–5 (Figure 1). All types were clearly distinguishable from 
each other with typical characteristics. However, they were 
not exclusive, and one patient could experience different 
types of episodic breathlessness. Eight patients described 
all types.
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Triggered episodes with normal levels of 
breathlessness (Type-1)
Five patients complained about episodes of breathlessness 
by exertion, which was comparable to the level of breathless-
ness of a healthy person during physical activity (Table 2). 
The severity of breathlessness was always strongly related to 
the level of exertion. Overall, patients who experienced this 
type showed lower severity scores for breathlessness:
I can do long walks but a little bit slower than before. (Male, 
71 years, MND)
Triggered episodes with predictable 
response (Type-2)
Nearly all patients (46 of 51, except those with Type-1) 
suffered from triggered episodic breathlessness with a pre-
dictable response. This was the typical type for exertional 
breathlessness, such as climbing stairs, talking and emo-
tions (e.g. panic, anger). The trigger was both the activator 
and worsening factor of episodic breathlessness. A certain 
level of trigger caused a predictable severity of breathless-
ness, and even slightest exertion could trigger severe 
breathlessness: ‘It depends what I am doing’ (male, 65 
years, LC). There was a broad variety of characteristics in 
terms of onset, recovery and length, and no distinct pat-
tern. However, a gradual increase and decrease of breath-
lessness severity was most common (Figure 2). The 
frequency of this type of episodic breathlessness was 
related to the patient’s exercise capacity, and therefore var-
ied. In terms of severity, patients described that although 
breathlessness could get really worse, they were still able 
to breathe and did not experience a sensation such as 
blocked airways (not able to breathe). Patients described 
several management strategies for exertional breathless-
ness such as avoiding exertion, pacing or using devices 
such as a stick or rollator:
It’s all related to exertion. If I were to walk up the stairs now I 
know damn well that if I stop twice I’ll be fine. (Male, 65 
years, LC)
Well I remember when I was much fitter if you go out for a run 
or something. You come back and you’re really fighting for 
breath. And it’s like that only a lot more severe. And it doesn’t 
take very much exertion. (Male, 70 years, MND)
Triggered episodes with unpredictable 
response (Type-3)
A few patients described a triggered type of episodic breath-
lessness with an unpredictable response, for example, get-
ting out of the car caused severe breathlessness but not 
always, and at the same time, heavy exertion like climbing 
stairs was possible without severe breathlessness. There 
was no relationship between the level of exertion and the 
severity of episodic breathlessness as described in the other 
two types of triggered episodes. This type occurred with a 
quick onset and severe intensity (Figure 2). It was only 
described by 5 of 51 patients, suffering either from COPD 
or CHF (Table 2). Patients struggle to cope with this type of 
episodes due to the unpredictability of the episode. Keeping 
calm and not aggravating breathlessness by panic were 
mentioned repeatedly as coping mechanisms:
I walked a mile the other week without any problems. Then 
over the weekend I got out of my car and immediately I became 
breathless. (Male, 66 years, CHF)
Non-triggered, unpredictable attack-like 
episodes (Type-4)
Twenty-two of 51 patients (43%) described a type of epi-
sodic breathlessness which came like an attack out-of-the-
blue without a warning signal or a trigger: ‘It really hits me’ 
(male, 79 years, COPD). Patients struggled with the unpre-
dictability of these episodes, as they could not prepare for it 
or prevent it often causing anxiety and panic:
It’s really out of the blue, all of a sudden, you never tell when it 
happens … there are no warning signals. (Male, 77 years, COPD)
I mean I can control it to a degree but when it kicks in I can’t 
control it. (Male, 69 years, COPD)
Figure 1. Types of episodic breathlessness.
COPD: chronic obstructive pulmonary disease.
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Figure 2. Patients’ graphs illustrating the pattern of different types of episodic breathlessness.
CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease.
Patients experiencing these attack-like episodes more often 
described loss of control compared to other types, and also 
reported panic and fear of death. Patients described these 
attack-like episodes as severe (intensity), with a quick onset 
and short duration (seconds or a few minutes), although 
longer durations occurred as well. The majority of patients 
Table 2. Frequency of types of episodic breathlessness (% in relation to the disease group; sum does not add up to 100% because 













CHF 15 1 (7) 14 (93) 2 (13)  9 (60) 1a (7)
LC 13 2 (15) 11 (85) 0 (0)  5 (38) 1b (8)
COPD 14 0 (0) 14 (100) 3 (21)  7 (50) 9 (64)
MND  9 2 (22)  7 (78) 0 (0)  1 (11) 0 (0)
Total 51 5 (10) 46 (90) 5 (10) 22 (43) 11 (22)
CHF: chronic heart failure; COPD: chronic obstructive pulmonary disease; LC: lung cancer; MND: motor neurone disease.
aPatient with CHF and asthma.
bPatient with lung cancer and COPD.
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in this group suffered from more severe breathlessness and 
18 of 22 (82%) patients experienced continuous breathless-
ness as well. Three patients described very short attacks, 
almost comparable to hiccups lasting only a few seconds: 
‘It’s almost a yawn’ (female, 66 years, COPD).
Triggered or non-triggered wave-like 
episodes in COPD (Type-5)
The majority of COPD patients described a type of epi-
sodic breathlessness that appeared similar to a wave; it 
gradually built to a maximum of severe breathlessness, 
then wearing off to normal breathing levels. Typically, 
patients felt warning signs such as chest tightness, pain-
ful breathing or coughing. This type of episodic breath-
lessness often lasts several minutes or sometimes even 
hours, with breathlessness intensity being much higher 
compared to normal fluctuations of existing breathless-
ness. However, patients had no means to interrupt this 
wave-like course. This was the only type that occurred 
triggered or non-triggered. Panic was the main worsening 
factor, which could potentially lead to emergency situa-
tions. Learning to control the panic was the most impor-
tant management strategy of this type: staying calm, 
relaxing and letting the episodes pass by. Patients empha-
sized that the knowledge ‘you will always be able to 
breathe’ was extremely helpful to keep control of the epi-
sode. This wave-like episode was COPD-specific; 
although not all patients with COPD described this type 
(9 of 14), all patients who experienced it suffered from 
COPD:
And you know it’s going to be happen. So you can’t stop it. 
(Female, 70 years, COPD)
Impact of episodes of breathlessness on 
daily life (all types)
Patients mainly experienced panic when they were not able 
to breathe during episodes of breathlessness. Some patients 
reported a fear of death when they felt like drowning or suf-
focating, while some described a ‘fear of the unknown’ 
about the unpredictability or unknown pattern of episodic 
breathlessness:
And there is nothing worse than not being able to breathe. […] 
It’s terrible and I fear to die. (Male, 64 years, MND)
But, er, I do hate how vulnerable it’s made me. […] And, er, 
it’s silly how much it affects you know, it’s, er – I won’t give 
in. (Female, 74 years, LC)
However, 8 of 51 patients stated that they did not experi-
ence panic during episodes of breathlessness. They had 
learnt effective management strategies by controlling the 
panic, for example, staying calm by knowing that they will 
not die during the episode and that the breathing would 
come back:
I don’t panic because I get used to it. (Female, 70 years, 
COPD)
Patients became frustrated about the limitations on 
activity and social life, often needing to rely on others. 
Some patients were concerned about the future, and some 
were well aware of the limited time. They feared episodes 
of breathlessness in the last moment of their life. However, 
these concerns were hard to distinguish from the general 
experience of breathlessness and did not seem to be spe-
cific to episodic breathlessness:
It’s got to be … my whole, er, life, the horizons have come in 
closer and closer and closer, geographically. Right? (Male, 65 
years, LC)
I really feel like I’m not here for long, erm, I feel like my days 
are getting numbered now. […] But I don’t want to worry my 
husband. (Female, 69 years, COPD)
Other patients were able to manage their lives and also 
breathlessness much more stoically:
I don’t get upset about talking about things, I know what’s 
going to happen. Like everybody you’re going to die but I’m 
going to die a bit earlier. (Male, 64 years, MND)
It doesn’t worry me. (Male, 71 years, MND)
Patients’ graphs illustrating the pattern of 
episodes of breathlessness
Thirty-nine graphs from 34 patients were analysed (18 
patients were not able to draw a graph because they 
were unwilling, had eye problems or did not understand 
the concept). The graphs were grouped into four differ-
ent categories (Table 3). The majority of graphs showed 
a quick onset and a slow recovery (group I) or similar 
time for onset and recovery (group II). Only four graphs 
described a slow onset and quick recovery (group III), 
and three graphs a recovery only (no onset, group IV). 
Only one graph could not be allocated to the four groups. 
This was a COPD patient (C-6) who drew two eleva-
tions (‘waves’), occurring straight after each other after 
30 min.
There was no strong relation between the four groups 
of graphs and the five types of episodic breathlessness, 
although typical patterns could be described and were 
representative for each type (Figure 2). There was a ten-
dency that the attack-like episode (Type-4) was more 
often related to group I (quick onset) and the triggered 
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predictable episode (Type-2) to group II (onset and 
recovery the same).
Discussion
We explored patients’ experiences of episodic breathlessness 
and were able to describe, for the first time, five different 
types of episodic breathlessness and different patterns. The 
two most important distinctions between the episodic breath-
lessness types are the relation to a trigger and whether the 
episode is predictable or not. The most common types are the 
triggered predictable episode (typical type for exertional 
breathlessness) and the non-triggered attack-like episode 
(unpredictable). The only disease-specific type is the wave-
like episode, which is described by patients with COPD. 
Following advances in the area of breakthrough pain (regard-
ing description and management strategies), a better under-
standing of episodic breathlessness and its pattern is essential 
for assessment and diagnoses of breathless patients in order to 
develop appropriate and effective management strategies.17,18 
The results of this study will deepen the understanding and 
differentiation of episodes of breathlessness, and need further 
verification in clinical practice and larger surveys.
Aggravated breathlessness following exertion (Type-2) 
was the most frequent type of episodic breathlessness in 
our study. The high frequency is supported by other studies 
in non-malignant pulmonary diseases (67 of 68 patients 
reported exertional breathlessness) or cancer patients 
(85%).19,20 Type-2 was always triggered and related to the 
level of the trigger, which was one of the main reasons for 
the limitation of patients’ activity, avoiding activity in order 
to reduce breathlessness.7 However, although breathless-
ness in this group could reach very severe levels, partici-
pants reported that they were always able to breathe. The 
knowledge that the episode will end and normal breathing 
will come back was an effective management strategy for 
this type of episodic breathlessness. The main characteris-
tic of the attack-like type was the lack of a trigger (unpre-
dictable) – this type came out-of-the-blue without any 
warning signal and was a real shock for the patient. 
Therefore, there was no chance for prevention. Not surpris-
ingly, patients did panic and lost control over the situation 
more often compared to other types. Although more than 
40% of patients in our study experienced this type of epi-
sodic breathlessness, it had rarely been described before. 
Two studies with 10 and 18 patients, respectively, described 
inexplicable episodic breathlessness occurring suddenly 
Table 3. Group analysis of patients’ graphs with characteristics of the graph, number of graphs and the number of graphs with a 
plateau.
Graph Characteristics Number of graphs With plateau
I. Quick onset Slow recovery 16 6
II. Onset and recovery the same 15 3
III. Slow onset Quick recovery  4 3
IV. Recovery only  3 –
Special Two waves  1 –
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without warning signs and wearing off again.7,21 In both 
studies, it was not clear whether these episodes were untrig-
gered (Type-4) or triggered (Type-3).7 In contrast to the 
first study, where this type appeared only in cancer and not 
in COPD patients, we found this type also in COPD 
patients, which was in accordance with three other stud-
ies.21–23 Interestingly, patients with continuous breathless-
ness and higher severity experienced the attack-like type in 
particular. This needs further exploration in quantitative 
studies with more participants.
It could be hypothesized that patients with different dis-
eases describe different patterns of episodic breathlessness. 
Our study does not support this theory as the majority of 
descriptions were similar across the four disease groups. 
The wave-like episode (Type-5) was the only disease-spe-
cific type related to COPD. Patients were not able to stop 
the occurrence and progress, but they could influence the 
pattern by controlling the panic, which was the key strategy 
to manage this type of episodic breathlessness. This type 
lasted mostly minutes or a few hours and was different 
from the experience of an exacerbation, which usually 
takes days or weeks to get back to normal life.24,25
Of the MND patients, only one reported an attack-like 
episode and none reported Type-3 or Type-4. This MND 
patient was only slightly impaired by the disease, without 
any co-morbidities that could support the hypothesis that 
MND at early stages only led to the triggered predictable 
type of breathless episode. In addition, MND patients often 
reported less panic and fear and seemed to be less con-
cerned about their situation and future expectations. This 
could be influenced by the fact that the clinic where MND 
patients were recruited was well known for their expertise 
and excellent support of MND patients. To our knowledge, 
only one study explored the experience of breathlessness in 
MND patients so far.26 This study described – in accord-
ance with our data – a coping strategy of MND patients ‘to 
live in the present’ and going on holidays when not affected 
too much by their illness.26
The impact of episodic breathlessness was often related 
to episodes in general (instead of a specific type) or even 
breathlessness in general. The experience of limitations of 
activity or social life, anxiety, panic or fear of death is well 
known in the breathlessness literature, and often reported 
by other studies.27
We had hoped that asking patients to draw the trajectory 
of their episodes would illustrate the different types of epi-
sodes more clearly. However, the analysis of the graphs 
did not support this as the patterns identified in the graphs 
did not show a strong relationship to the described types of 
episodic breathlessness, but typical patterns did appear. 
Nevertheless, we think that asking a patient to draw a 
graph of the experienced breathless episode is useful for 
better understanding of the individual pattern, rather than 
to characterize different types of episodic breathlessness 
across patients.
Strengths and limitations
This qualitative exploration revealed the description of epi-
sodes of breathlessness across different conditions, which 
allow comparison between groups.
This study used a qualitative, explorative study design, 
and therefore, proportions and frequencies have to be taken 
with caution. To determine prevalences of the different 
types of breathlessness episodes, a larger quantitative study 
is necessary. In addition, experiences of breathless episodes 
were collected retrospectively, and therefore, data could be 
influenced by recall bias. As this is an explorative study, the 
results need to be verified by a prospective study.
Implications for clinical care and research
In accordance with Lansing et al.,28 a better understanding 
of the multidimensional character of breathlessness and its 
diversity and differences should improve therapeutic effi-
cacy by better assessment, diagnosis and the development 
of effective treatment. The description of different types of 
episodes of breathlessness is a first step in this way. 
Clinicians’ assessment should include an accurate history 
of breathless episodes, in order to tailor individualized 
treatment and to find appropriate and type-specific man-
agement strategies. These strategies are likely to vary 
between the different types, for example, focused on the 
trigger for Type-2 and coping related for the attack-like 
type. The development of effective management strategies 
is the next important step and should be type-specific to 
address the diversity of episodic breathlessness. 
Management strategies should include non-pharmacologi-
cal and pharmacological options. In addition, the presented 
types need to be confirmed in a larger survey across differ-
ent diseases.
In conclusion, similar to advances in breakthrough pain 
over the last decades, much more effort in clinical care and 
research is necessary in the future to reduce the burden 
caused by episodes of breathlessness. The description of 
different types of episodes of breathlessness will inform 
this development.
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